Cargando…
First Do No Harm: Moving Beyond Universal Preprocedural Testing for COVID-19
Preprocedural testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was introduced early in the pandemic in an effort to protect health care workers, direct appropriate use of personal protective equipment (PPE), and improve patient outcomes. In light of our appreciation for the e...
Autores principales: | Penney, Jessica, Shah, Sajani, Doron, Shira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313515/ https://www.ncbi.nlm.nih.gov/pubmed/34322568 http://dx.doi.org/10.1093/ofid/ofab342 |
Ejemplares similares
-
Managing the risks of making the wrong diagnosis: First, do no harm
por: Olliaro, Piero, et al.
Publicado: (2021) -
Moving beyond the GM Debate
por: Leyser, Ottoline
Publicado: (2014) -
The Importance of Universal Preprocedural Testing for the Novel Coronavirus 2019
por: Zhang, Felicia, et al.
Publicado: (2020) -
Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
por: Ketchum, Fred B., et al.
Publicado: (2022) -
Moving Beyond Directly Observed Therapy for Tuberculosis
por: Metcalfe, John Z., et al.
Publicado: (2015)